Affibody reports progress on molecular imaging

02/11/2008 | PharmaLive.com

Swedish molecular-imaging company Affibody Holding AB saw an increase in revenue in 2007 and reported progress on molecules for molecular imaging. "We focused our resources on our second-generation Affibody molecules and are on track to commence the first clinical study with our lead cancer imaging product ABY-025 in mid-2008," the company's CEO said in a news release.

View Full Article in:

PharmaLive.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN